US stocks struggled last week as President Donald Trump failed to gather majority on health care reform in Congress which raised questions about his ability to push through other key reforms promised in his election campaigns such as tax cuts and fiscal spending to boost the economy.
Saurabh Mukherjea, CEO, Ambit Capital believes the economic weakness and the rally against is making it uncomfortable to chase the rally. He believes IT and pharma have a few stocks with attractive valuations even if both the sectors are seeing some pressure.
Harsha Upadhyaya of Kotak Mutual Fund is upbeat on the market and asserted that the fund house stayed invested in it despite DII selling. He believes earnings growth have improved and will continue the trend in March as well.